The chronic hepatitis D virus market is expected to grow steadily, driven by a relatively small pipeline of emerging therapies. Leading candidates, such as Brelovitug from Bluejay Therapeutics and the ...

The chronic hepatitis D virus market is expected to grow steadily, driven by a relatively small pipeline of emerging therapies. Leading candidates, such as Brelovitug from Bluejay Therapeutics ...

Wisconsin guard Laci Steele fights to keep possession against Oregon's Sofia Bell, left, and Mia Jacobs during a Big Ten Conference game on Sunday, Jan. 18 at the Kohl Center in M ...

Dominic has spent a few months with the Sennheiser hd 800 S headphones and the hdv 820 amplifier - a pairing costing around £3,500. Just how good are they?

Detailed price information for S&P 500 Ishares Core ETF (IVV-A) from The Globe and Mail including charting and trades.

Professional video editing, simplified ...

The Trump Administration proposed massive cuts to Immigration and Customs Enforcement’s body camera programme for this ...

In January 2026, Vir Biotechnology reported new positive data from its ongoing SOLSTICE Phase 2 trial in chronic hepatitis delta, where combination therapy with investigational agents tobevibart and ...

The cystinosis therapeutic landscape remains dominated by established cysteamine-based treatments, with limited availability of next-generation, curative, or truly disease-modifying options. However, ...

The Lakers have found their standard. The execution is the ultimate test. "Hopefully we can find that consistency," JJ Redick ...

Beta measures price volatility relative to the S&P 500; beta is calculated from five-year weekly returns. The 1-yr return represents total return over the trailing 12 months. VIG is marginally less ...

Chevron shares are up on Thursday as the company navigates complex geopolitical landscapes, particularly regarding potential investments in Venezuela.